Under construction – not a live service
Sign in
Not yet taking people in ChinaNo phase

A Multicenter Study of Artificial Intelligence Model for Fetal Congenital Heart Disease

Key facts

Where
Beijing, ChinaSee the site

Where in China

  • Beijing Anzhen Hospital Affiliated to Capital Medical UniversityBeijing, ChinaNo longer taking part

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Trial details

Who runs it
Beijing Anzhen Hospital
Trial code
NCT06796127
Record updated
28 January 2025
Original description
This study addresses congenital heart disease in fetuses, a specific birth defect, by collaborating with multicenter medical institutions across China. It prospectively collects echocardiographic screening, diagnostic images, and structured parameter data from both normal and abnormal fetuses. Cases are followed up, and artificial intelligence (AI) models are developed to extract fetal heart echocardiographic image features and analyze the data. This process allows for the analysis of the AI models' accuracy, sensitivity, and specificity, and verifies the application value of AI models in fetal heart echocardiographic screening and diagnosis.Read full original descriptionShow less

Beijing Anzhen Hospital

This study addresses congenital heart disease in fetuses, a specific birth defect, by collaborating with multicenter medical institutions across China. It prospectively collects echocardiographic screening, diagnostic images, and structured parameter data from both normal and abnormal fetuses. Cases are followed up, and artificial intelligence (AI) models are developed to extract fetal heart echocardiographic image features and analyze the data. This process allows for the analysis of the AI models' accuracy, sensitivity, and specificity, and verifies the application value of AI models in fetal heart echocardiographic screening and diagnosis.

Inclusion: Single or multiple pregnancy; Gestational age 16-40 weeks; Fetal echocardiographic images are clear and complete; Clinical data are complete and detailed; Sign informed consent and be able to cooperate with follow-up.

Exclusion: Fetal echocardiographic images are incomplete or of poor quality that cannot be used for research; Refusal or loss of follow-up.

ClinicalTrials.gov NCT06796127